Wake Forest University
Hospitals Figuring Out How to Incorporate Beta-Amyloid Testing in Standard Clinical Practice
Premium
Spurred by newly available beta-amyloid-targeting drugs, hospitals are exploring how to diagnose Alzheimer's patients early and determine their treatment.
Consortium Focused on Identifying Chronic Pain Biomarkers Gets $1.9M Boost
The additional funds from the National Institute on Drug Abuse will allow the Acute to Chronic Pain Signatures Consortium to keep researching biomarkers that can predict which patients are at risk.
Wake Forest Organoid Research Center Receives $2.5M NCI Grant
Researchers will use the grant to develop a drug testing platform using patient-derived tumor organoids to predict treatment outcomes for patients.
New FDA Program May Help Oncologists Access Investigational Drugs in Precision Medicine Era
The program, called Project Facilitate, aims to help oncologists request access to investigational drugs but may only simplify part of the process.
The researchers found differences in mutational patterns among their African-American patients and that liquid biopsies seem to catch metastases early.